Clinical Trial Update: Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of cilostazol for nonalcoholic fatty liver disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Tanta University | Conditions: Fatty Liver | Phase 1, Phase 2 | Status: RECRUITING